leadf
logo-loader
LSE:NFX

Nuformix PLC

Receive alerts
Market:
LSE
Market Cap:
£13.69 m
Price
2.67 GBX
Change
-4.73%
52 weeks high
11.20
52 weeks low
2.55

In brief

Nuformix is a pharmaceutical development company focused on unlocking the therapeutic potential and value of known drugs to develop new novel medicines to provide enhanced benefit with  lead programmes in fibrosis and oncology supportive care .

Snapshot

Oxilio took out an option on NXP001 in oncology in September